因帶有占所有肺癌病人隻1%~2%的RET變異,所以才會對新靶向藥BLU-667(或LOXO-292)如此敏感。
因帶有占所有肺癌病人隻1%~2%的RET變異,所以才會對新靶向藥BLU-667(或LOXO-292)如此敏感。
WENXUECITY.COM does not represent or guarantee the truthfulness, accuracy, or reliability of any of communications posted by other users.
Copyright ©1998-2024 wenxuecity.com All rights reserved. Privacy Statement & Terms of Use & User Privacy Protection Policy